agrees guidant
pharmaceutical giant johnson johnson medical technology guidant
guidant producer equipment combats heart implant defibrillators pacemakers analysts offsetting johnson johnson reliance slowing drug mergers drug healthcare industries fragmented johnson johnson products patent expirations battling fierce competition generic products demand defibrillators heart electric shock irregular heartbeat rhythm detected analysts johnson johnson guidant closing price analysts antitrust regulators firms overlapping stent operations stents tubes artery unblocked
